Targeting Bacterial Genomes for Natural Product Discovery

Publication date: Available online 7 December 2019Source: Trends in Pharmacological SciencesAuthor(s): Edward Kalkreuter, Guohui Pan, Alexis J. Cepeda, Ben ShenBacterial natural products (NPs) and their analogs constitute more than half of the new small molecule drugs developed over the past few decades. Despite this success, interest in natural products from major pharmaceutical companies has decreased even as genomics has uncovered the large number of biosynthetic gene clusters (BGCs) that encode for novel natural products. To date, there is still a lack of universal strategies and enabling technologies to discover natural products at scale and speed. This review highlights several of the opportunities provided by genome sequencing and bioinformatics, challenges associated with translating genomes into natural products, and examples of successful strain prioritization and BGC activation strategies that have been used in the genomic era for natural product discovery from cultivatable bacteria.
Source: Trends in Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research